Chemmino dedicates to developing and utilizing a range of novel illuminating materials to design, develop, and manufacture a series of miniature yet affordable diagnostic devices for point-of-care and even consumer level biomedical analyses.

GoldPorp Pharma dedicates to the discovery and clinical development of novel drugs for the treatment of advanced cancer. We envision a world where advanced cancer is just a treatable chronic disease. We have developed proprietary anticancer compounds that provide much better efficacy than commonly used platinum-based cancer drugs for treatment of advanced metastasized cancer and potentially replace existing chemotherapy.

L'Ord'invent Limited aims at inventing, devising, and refining rapid tools for diagnosing early cancer and prediction of cancer onset, treatment response and relapse. Also aims to transform rapid tools from hospital/laboratory tests to point-of-care and home self-monitoring tests.

ChemTechChem is dedicated to developing technologies and multi-omics platforms, which support basic and translational research in drug discovery. The platforms generate integrated big data to build robust and rigorous repositories (e.g. Omics Suite, Omics Atlas, Biobank) – translating omics insights into predictable outcomes - for the discovery of new targeted chemotherapy against advanced and metastatic cancers.

AILSI is a biotechnology company powered by generative artificial intelligence. AILSI has developed a comprehensive AI system that integrates disease biology with medicinal chemistry. By utilizing advanced deep learning techniques, along with internally developed computational biology tools and molecular modeling methods, they focus on discovering new targets and designing innovative drug candidates to address unmet clinical needs.